超声引导下麦默通旋切系统在触诊阴性乳腺病灶诊断中的应用

目的探讨超声引导下麦默通旋切系统对触诊阴性乳腺病灶的诊断优势及意义。方法2014年1月~2015年9月我院所收治经超声诊断而临床触诊阴性病灶的341例患者采用超声引导下麦默通旋切系统旋切并对其中164例患者进行了BARD活检针穿刺活检，回顾分析了相应患者的临床资料，分析了麦默通旋切系统较BARD活检穿刺针的诊治优势，同时对常见并发症进行探讨。结果341例麦默通旋切患者穿刺成功率为100%，164例BARD活检穿刺针患者穿刺成功率为82.19%，麦默通旋切组标本病检阳性率为100%，而BARD活检穿刺针组阳性率仅为76.1%。341例患者中仅5例患者出现轻微皮下瘀斑，3例患者出现术后血肿。结论针对触诊阴性的乳腺病灶，在超声引导下行麦默通旋切活检术具有微创、安全、成功率高、并发症少的优势，对触诊阴性乳腺病灶的诊治具有重要意义。

Clinical application of mammotome minimally invasive biopsy system under the guide of ultrasound on nonpalpable breast Lesions

Objective To assess the advantage and value of Mammotome minimally invasive biopsy system under the guide of ultrasound on Nonpalpable Breast Lesions. Methods We counted 341 patients with nonpalpable breast lesions who diagnosed by ultrasound, all the patients obtained Mammotome minimally invasive biopsy guided by ultrasound, 146 of also obtained BARD biopsy needle aspiration biopsy ,and then analyzed by pathological examination，the cause for complications was analysed and the control strategy was studied. Results The success ratios of sample choosing for Mammotome minimally invasive biopsy system and BARD biopsy needle were 100％ and 82.19％, respectively．The coincident ratios of pathological diagnosis of Mammotome minimally invasive biopsy system and BARD biopsy were 100％ and76.1％, respectively. In the 341 patients, only 5 patients with slight subcutaneous ecchymosis and 3 patients with hematoma. Conclusions For the nonpalpable breast lesions, Mammotome minimally invasive biopsy system under the guide of ultrasound has the advantages of minimally invasive, safe, high success rate and less complications, so it has an important significance in diagnosis and treatment of nonpalpable breast lesions